(GTLB) Gitlab - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 4.513m USD | Total Return: -44.3% in 12m
Avg Turnover: 123M
Qual. Beats: 1
Rev. Trend: 99.9%
Qual. Beats: 3
Warnings
Altman Z'' -0.66 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
GitLab Inc. provides a comprehensive DevSecOps platform designed to manage the entire software development lifecycle within a single application. The company’s core offering integrates project planning, source code management, security auditing, and deployment configurations into a unified workflow. Recently, GitLab expanded its capabilities with the GitLab Duo Agent Platform, which utilizes conversational AI and autonomous agents to automate specialized tasks across the development pipeline.
Operating within the Systems Software sub-industry, GitLab utilizes a Software-as-a-Service (SaaS) and self-managed subscription model. This sector is increasingly focused on toolchain consolidation, where enterprises replace multiple fragmented point solutions with single platforms to reduce operational complexity and security vulnerabilities. By embedding security scans and compliance checks directly into the development process-a practice known as shifting left-GitLab addresses the growing demand for secure software delivery.
Investors can further analyze these competitive dynamics and valuation metrics on ValueRay. GitLab was founded in 2011 and is headquartered in San Francisco, California.
- Enterprise customer migration to consolidated DevSecOps platforms accelerates subscription revenue growth
- Integration of AI-powered GitLab Duo agents increases average revenue per user
- Competitive pressure from Microsoft GitHub influences pricing power and market share
- Expansion of security and compliance features drives adoption among regulated industries
- Shift in enterprise IT spending impacts high-growth software-as-a-service valuation multiples
| Net Income: -56.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 17.73 > 1.0 |
| NWC/Revenue: 105.1% < 20% (prev 104.2%; Δ 0.85% < -1%) |
| CFO/TA 0.14 > 3% & CFO 232.9m > Net Income -56.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (165.8m) vs 12m ago -2.52% < -2% |
| Gross Margin: 87.36% > 18% (prev 0.89%; Δ 8.65k% > 0.5%) |
| Asset Turnover: 61.19% > 50% (prev 54.26%; Δ 6.93% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.58 (Total Current Assets 1.66b - Total Current Liabilities 652.1m) / Total Assets 1.72b |
| B: -0.71 (Retained Earnings -1.22b / Total Assets 1.72b) |
| C: -0.05 (EBIT TTM -70.5m / Avg Total Assets 1.56b) |
| D: -1.77 (Book Value of Equity -1.22b / Total Liabilities 686.5m) |
| Altman-Z'' = -0.66 = B |
| DSRI: 0.87 (Receivables 304.3m/278.5m, Revenue 955.2m/759.2m) |
| GMI: 1.02 (GM 87.36% / 88.79%) |
| AQI: 0.77 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 1.26 (Revenue 955.2m / 759.2m) |
| TATA: -0.17 (NI -56.0m - CFO 232.9m) / TA 1.72b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 26.73 with a total of 3,014,209 shares traded.
Over the past week, the price has changed by +12.98%,
over one month by +24.27%,
over three months by +7.22% and
over the past year by -44.31%.
Gitlab has received a consensus analysts rating of 4.54. Therefore, it is recommended to buy GTLB.
- StrongBuy: 18
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 30.3 | 13.4% |
P/E Forward = 33.2226
P/S = 4.725
P/B = 4.5559
Revenue TTM = 955.2m USD
EBIT TTM = -70.5m USD
EBITDA TTM = -59.1m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 187k USD (Leases only: 187k)
Net Debt = -1.26b USD (calculated: Debt 187k - CCE 1.26b)
Enterprise Value = 3.25b USD (4.51b + Debt 187k - CCE 1.26b)
Interest Coverage Ratio = unknown (Ebit TTM -70.5m / Interest Expense TTM 0.0)
EV/FCF = 14.65x (Enterprise Value 3.25b / FCF TTM 222.0m)
FCF Yield = 6.82% (FCF TTM 222.0m / Enterprise Value 3.25b)
FCF Margin = 23.24% (FCF TTM 222.0m / Revenue TTM 955.2m)
Net Margin = -5.86% (Net Income TTM -56.0m / Revenue TTM 955.2m)
Gross Margin = 87.36% ((Revenue TTM 955.2m - Cost of Revenue TTM 120.7m) / Revenue TTM)
Gross Margin QoQ = 86.57% (prev 86.81%)
Tobins Q-Ratio = 1.89 (Enterprise Value 3.25b / Total Assets 1.72b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 187k)
Taxrate = 21.0% (US default 21%)
NOPAT = -55.7m (EBIT -70.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.54 (Total Current Assets 1.66b / Total Current Liabilities 652.1m)
Debt / Equity = 0.00 (Debt 187k / totalStockholderEquity, last quarter 990.7m)
Debt / EBITDA = 21.30 (negative EBITDA) (Net Debt -1.26b / EBITDA -59.1m)
Debt / FCF = -5.67 (Net Debt -1.26b / FCF TTM 222.0m)
Total Stockholder Equity = 897.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.58% (Net Income -56.0m / Total Assets 1.72b)
RoE = -2.64% (Net Income TTM -56.0m / Total Stockholder Equity 2.12b)
RoCE = -6.58% (EBIT -70.5m / Capital Employed (Total Assets 1.72b - Current Liab 652.1m))
RoIC = -6.20% (negative operating profit) (NOPAT -55.7m / Invested Capital 898.3m)
WACC = 11.61% (E(4.51b)/V(4.51b) * Re(11.61%) + D(187k)/V(4.51b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 11.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 3.00%
[DCF] Terminal Value 64.91% ; FCFF base≈222.0m ; Y1≈222.9m ; Y5≈236.2m
[DCF] Fair Price = 23.76 (EV 2.36b - Net Debt -1.26b = Equity 3.62b / Shares 152.5m; r=11.61% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.00 | # QB: 1
Revenue Correlation: 99.87 | Revenue CAGR: 30.10% | SUE: 3.49 | # QB: 3
EPS current Quarter (2026-07-31): EPS=0.19 | Chg30d=+0.05% | Revisions=+0% | Analysts=27
EPS current Year (2027-01-31): EPS=0.79 | Chg30d=-0.10% | Revisions=+0% | GrowthEPS=-17.6% | GrowthRev=+16.5%
EPS next Year (2028-01-31): EPS=0.98 | Chg30d=-0.22% | Revisions=-43% | GrowthEPS=+24.1% | GrowthRev=+16.0%
[Analyst] Revisions Ratio: -43%